Form 8-K SYNERGY PHARMACEUTICALS, For: May 16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Synergy Pharma (SGYP) Gains as Paulson & Co. Loads Up
May 17, 2016 9:25 AM EDTSynergy Pharma (NASDAQ: SGYP) is gaining in pre-open trade after John Paulson's, Paulson & Co, disclosed that it owned 27,756,668 shares as of 05/04/16, according to a new Form 4 filing.
This is up from the 9,000,000 shares held at the end of the year 2016 and the 11,090,000... More
